Finchley Research & Development

Finchley Research & Development is a UK-based pharmaceutical research and development company that operates as a subsidiary of Viatris. The company specializes in the development of complex generic medicines and biosimilars, with a particular emphasis on respiratory health and inhalation technologies. Based in Hatfield, it serves as a key technical hub for the global Viatris network, managing the lifecycle of products from early-stage formulation to regulatory approval. Its work supports a broad portfolio of treatments for chronic conditions such as asthma and COPD, contributing to the parent company's mission of providing sustainable access to high-quality medicines. The entity plays a vital role in bridging the gap between innovative drug design and large-scale manufacturing for global markets.